499 related articles for article (PubMed ID: 26642350)
1. Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid.
Parés A
Dig Dis; 2015; 33 Suppl 2():125-33. PubMed ID: 26642350
[TBL] [Abstract][Full Text] [Related]
2. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
3. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review.
Suraweera D; Rahal H; Jimenez M; Viramontes M; Choi G; Saab S
Liver Int; 2017 Dec; 37(12):1877-1886. PubMed ID: 28517369
[TBL] [Abstract][Full Text] [Related]
4. Novel Treatment Strategies for Primary Biliary Cholangitis.
Parés A
Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
[TBL] [Abstract][Full Text] [Related]
5. Advances in pharmacotherapy for primary biliary cirrhosis.
Mousa HS; Lleo A; Invernizzi P; Bowlus CL; Gershwin ME
Expert Opin Pharmacother; 2015 Apr; 16(5):633-43. PubMed ID: 25543678
[TBL] [Abstract][Full Text] [Related]
6. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Angulo P; Jorgensen RA; Keach JC; Dickson ER; Smith C; Lindor KD
Hepatology; 2000 Feb; 31(2):318-23. PubMed ID: 10655252
[TBL] [Abstract][Full Text] [Related]
7. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
8. Novel Aspects in the Management of Cholestatic Liver Diseases.
Chazouillères O
Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
[TBL] [Abstract][Full Text] [Related]
9. Treatment of primary biliary cirrhosis with ursodeoxycholic acid, budesonide and fibrates.
Poupon R
Dig Dis; 2011; 29(1):85-8. PubMed ID: 21691111
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapies on Primary Biliary Cirrhosis.
Czul F; Levy C
Clin Liver Dis; 2016 Feb; 20(1):113-30. PubMed ID: 26593294
[TBL] [Abstract][Full Text] [Related]
11. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
Bowlus CL; Kenney JT; Rice G; Navarro R
J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis and bile acids.
Corpechot C
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S13-20. PubMed ID: 23141888
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
Gómez E; Montero JL; Molina E; García-Buey L; Casado M; Fuentes J; Simón MA; Díaz-González A; Jorquera F; Morillas RM; Presa J; Berenguer M; Conde MI; Olveira A; Macedo G; Garrido I; Hernández-Guerra M; Olivas I; Rodríguez-Tajes S; Londoño M; Sousa JM; Ampuero J; Romero-González E; González-Padilla S; Escudero-García D; Carvalho A; Santos A; Gutiérrez ML; Pérez-Fernández E; Aburruza L; Uriz J; Gomes D; Santos L; Martínez-González J; Albillos A; Fernández-Rodríguez CM
Aliment Pharmacol Ther; 2024 Jun; 59(12):1604-1615. PubMed ID: 38690746
[TBL] [Abstract][Full Text] [Related]
14. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
[TBL] [Abstract][Full Text] [Related]
15. Old and new treatments for primary biliary cholangitis.
Chascsa D; Carey EJ; Lindor KD
Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone.
Rabahi N; Chrétien Y; Gaouar F; Wendum D; Serfaty L; Chazouillères O; Corpechot C; Poupon R
Gastroenterol Clin Biol; 2010; 34(4-5):283-7. PubMed ID: 20417047
[TBL] [Abstract][Full Text] [Related]
18. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
Levy C
Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
[TBL] [Abstract][Full Text] [Related]
19. Improving prognosis in primary biliary cholangitis - Therapeutic options and strategy.
Harms MH; van Buuren HR; van der Meer AJ
Best Pract Res Clin Gastroenterol; 2018; 34-35():85-94. PubMed ID: 30343714
[TBL] [Abstract][Full Text] [Related]
20. Primary biliary cirrhosis in adults.
Momah N; Lindor KD
Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):427-33. PubMed ID: 24580040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
